Sabra Health Care REIT Inc
NASDAQ:SBRA

Watchlist Manager
Sabra Health Care REIT Inc Logo
Sabra Health Care REIT Inc
NASDAQ:SBRA
Watchlist
Price: 20.07 USD -2.53% Market Closed
Market Cap: $5B

Sabra Health Care REIT Inc
Investor Relations

Sabra Health Care REIT Inc. emerged as a crucial player in the health care real estate sector, weaving its business model around the dynamic needs of senior living and specialized health facilities. Founded in 2010, Sabra was born from the idea of providing reliable financial support to health care operators by investing in their real estate. As a real estate investment trust (REIT), Sabra acquires, owns, and leases properties to operators of skilled nursing facilities, senior housing communities, and hospitals across the United States and Canada. The company derives its income primarily through lease payments from tenants, often structured as triple-net leases, where the operators bear responsibilities for property expenses such as maintenance, insurance, and taxes, ensuring Sabra receives steady, predictable cash flows.

Sabra's strategy involves building a diversified portfolio to mitigate risks, investing in a range of facility types, each catering to different demographics and health care needs. This strategic diversity is a testament to Sabra's understanding of the market's cyclical nature and its adaptability to regulatory changes in the health care environment. The management team at Sabra is seasoned and places significant emphasis on maintaining quality relationships with their operators, ensuring the facilities are not just functional but thrive in providing critical services. By effectively leveraging their real estate assets and adapting to industry trends, Sabra not only contributes to the health care ecosystem but also locks in long-term profitability avenues, all while navigating the complexities of a heavily regulated sector.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2025
Call Date
Feb 13, 2026
AI Summary
Q4 2025

FFO/AFFO Growth: Sabra guided to 4.9% and 5.4% midpoint growth in normalized FFO and normalized AFFO per share for 2026, reflecting ongoing operational strength.

Strong SHOP Results: The managed senior housing (SHOP) portfolio showed impressive sequential revenue and NOI growth, with occupancy gains and margin expansion.

Investment Pipeline: Sabra expects to materially exceed 2025's $450 million investment volume in 2026, already closing or awarding $240 million of deals early in the year.

Occupancy Gains: Same-store senior housing occupancy rose 160 bps year-over-year to 87.9%, with Canadian assets exceeding 94%. Management expects low 90s occupancy soon.

Canadian Outperformance: Canadian senior housing assets had stronger RevPOR and occupancy growth than US peers, with continued expectations for high performance.

Guidance Introduced: 2026 guidance includes normalized FFO per share of $1.49–$1.53 and normalized AFFO per share of $1.55–$1.59, both up ~5% at midpoint.

Dividend: A quarterly cash dividend of $0.30 per share was declared, covered by AFFO with a 79% payout ratio.

Leverage & Liquidity: Leverage held steady at 5.0x net debt/EBITDA, with $1.2 billion in liquidity and no floating rate permanent debt.

Key Financials
Normalized FFO per Share
$0.36
Normalized AFFO per Share
$0.38
Normalized FFO
$91.2 million
Normalized AFFO
$95.2 million
SHOP Portfolio Revenue Growth
15.8% sequential
SHOP Portfolio Cash NOI Growth
18.4% sequential
SHOP Portfolio Margin Expansion
60 bps sequential
SHOP Cash NOI
$35.6 million
Interest and Other Income
$10.6 million
Cash Interest Expense
$26.6 million
Cash G&A
$12.5 million
Same-store Managed Senior Housing Revenue Growth
6.4% year-over-year
Same-store Managed Senior Housing Cash NOI Growth
12.6% year-over-year
Same-store Managed Senior Housing Occupancy
87.9%
Same-store Domestic Portfolio Occupancy
84.7%
Same-store Canadian Portfolio Occupancy
94.2%
RevPOR Growth (overall)
4.2% YoY
RevPOR Growth (Canada)
5.2% YoY
exPOR Growth
1.6% YoY
Net Debt to Adjusted EBITDA
5.00x
Permanent Debt Cost
3.92%
Weighted Average Debt Term
4.2 years
Liquidity
$1.2 billion
Unrestricted Cash & Equivalents
$71.5 million
Revolver Availability
$782.4 million
Outstanding ATM Forward Contracts
$322.7 million at $18.60 per share avg
Available under ATM Program
$483 million
Quarterly Dividend per Share
$0.30
Dividend Payout Ratio (AFFO)
79%
Investment Volume (2025)
$450 million
Awarded Deals in Process (early 2026)
$240 million
Initial Cash Yield on 2025 Investments
7.5%
Other Earnings Calls

Management

Mr. Richard K. Matros
Chairman, President & CEO
No Bio Available
Mr. Michael Lourenco Costa CPA
Executive VP, CFO & Secretary
No Bio Available
Ms. Talya Nevo-Hacohen
Executive VP, Chief Investment Officer & Treasurer
No Bio Available
Ms. Jessica Flores
Executive VP, Chief Accounting Officer & Principal Accounting officer
No Bio Available
Mr. Peter W. Nyland
Executive Vice President of Asset Management
No Bio Available
Mr. Darrin L. Smith
Executive Vice President of Investments
No Bio Available
Mr. Lukas Michael Hartwich C.F.A.
Senior Vice President of Finance
No Bio Available
Ms. Eliza Gozar
Senior Vice President of Investments
No Bio Available

Contacts

Address
CALIFORNIA
Irvine
18500 von Karman Ave Ste 550
Contacts
+18883938248.0
www.sabrahealth.com